Stephan Hjorth

Integrative Pharmacology, AstraZeneca R&D, Molndal, Sweden 
CNS, appetite, serotonin, cannabinoid, in vivo
"Stephan Hjorth"
Mean distance: 17.32 (cluster 6)
Cross-listing: Chemistry Tree

BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Hjorth S, Waters S, Waters N, et al. (2020) . The Journal of Pharmacology and Experimental Therapeutics
Waters S, Sonesson C, Svensson P, et al. (2020) Preclinical pharmacology of [2-(3-fluoro-5-methanesulfonylphenoxy)ethyl](propyl)amine (IRL790), a novel dopamine transmission modulator for the treatment of motor and psychiatric complications in Parkinson's disease. The Journal of Pharmacology and Experimental Therapeutics
Jansson-Löfmark R, Hjorth S, Gabrielsson J. (2020) Does in vitro potency predict clinical efficacious concentrations? Clinical Pharmacology and Therapeutics
Näslund I, Hjorth S, Carlsson LMS. (2019) Revisions of Gastric Bypass-A Moral Obligation-Reply. Jama Surgery
Hjorth S, Näslund I, Andersson-Assarsson JC, et al. (2019) Reoperations After Bariatric Surgery in 26 Years of Follow-up of the Swedish Obese Subjects Study. Jama Surgery
Gabrielsson J, Andersson R, Jirstrand M, et al. (2019) Dose-Response-Time Data Analysis: An Underexploited Trinity. Pharmacological Reviews. 71: 89-122
Gabrielsson J, Peletier LA, Hjorth S. (2018) Lost in translation: What's in an EC? Innovative PK/PD reasoning in the drug development context. European Journal of Pharmacology
Carlsson LMS, Sjöholm K, Ahlin S, et al. (2018) Long-term incidence of serious fall-related injuries after bariatric surgery in Swedish obese subjects. International Journal of Obesity (2005)
Gabrielsson J, Peletier LA, Hjorth S. (2017) In vivo potency revisited - Keep the target inl sight. Pharmacology & Therapeutics
Carlsson LM, Sjöholm K, Karlsson C, et al. (2017) Long-term incidence of microvascular disease after bariatric surgery or usual care in patients with obesity, stratified by baseline glycaemic status: a post-hoc analysis of participants from the Swedish Obese Subjects study. The Lancet. Diabetes & Endocrinology
See more...